Delivery of ultrasound equipment to the Maria Skłodowska-Curie National Institute of Oncology – National Research Institute, Gliwice Branch Text automatically translated in your browsing language Automatically translated

1.The subject matter of this contract is the supply of ultrasound equipment to the Maria Skłodowska-Curie National Institute of Oncology – National Research Institute Branch in Gliwice, hereinafter referred to as the Contracting Authority. 2. The description of the subject of the contract and the conditions for the performance of the contract are set out in the annexes: - Assortment and price specifications – Annex 2 to the SWZ, - Technical parameters – Annex 3 to the SWZ, - Draft provisions of the contract to be incorporated into the contract – Annex 5 to the SWZ. 3. Tenders not containing the full scope of the subject of the contract will be rejected. 4. The contracting authority allows equivalent tenders to be submitted - the description of equivalence is contained in Chapter IV of the SWZ. 5. The Contracting Authority does not provide for electronic auctions or supplementary contracts. 6. Information on joint bids by contractors is provided in Chapter IX of the SWZ. 7. The Contracting Authority provides for the possibility of changing the provisions of the concluded agreement (so-called contractual changes based on Art. 1 point 1 of the Act) in relation to the content of the tender on the basis of which the Contractor was selected, in accordance with the conditions set out in Annex 5 to the SWZ. The contract may also be amended in the cases referred to in Art. 1 points 2-4 and par. 2 of the PPL Act. 8. An information clause resulting from Article 13 of Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC, was included by the Ordering Party in the SWZ. 9. The successful tenderer shall be required, before the conclusion of the public contract, to lodge a performance guarantee equal to 5 % of the total price quoted in the tender. 10. The contracting authority shall require the submission of the means of proof in question: declaration of conformity and/or CE certificate (depending on the class of medical device) and relevant statements (if required) - the document is to confirm that the offered device complies with Regulation 2017/745 on medical devices (MDR) or with Council Directive 93/42/EEC (MDD) together with subsequent transitional provisions. The above documents constituting the means of proof in question are to confirm that the subject of the contract offered corresponds to the requirements specified by the Ordering Party. Having regard to Article 107(1) of the Treaty on the Functioning of the European Union, 2 of the Public Procurement Act, the Contracting Authority informs that the means of proof in question are to be supplemented if they are not submitted with the offer or are incomplete. 11. Detailed information on the present proceedings is contained in the SWZ. 12. The Contracting Authority informs that the subject of the contract in this procedure is financed under the project "Development of the Clinical Research Support Centre of the National Cancer Institute Branch in Gliwice" implemented and co-financed under the National Recovery and Resilience Plan Component D Efficiency, accessibility and quality of the health care system Investment D3.1.1 Comprehensive development of research in the field of medical sciences and health sciences, contract No KPOD.07.07-IW.07-0331/24. Pursuant to Article 257 of the Public Procurement Law, the Contracting Authority provides for the possibility of cancelling the procurement procedure if the public funds that the Contracting Authority intended to allocate to finance all or part of the contract are not awarded to it. 13.The contracting authority informs that the contract must comply with the "DNSH principle" ("do no significant harm"; Eng. ‘Do No Significant Harm’), which is the principle of not supporting or conducting an economic activity that causes significant harm (serious harm, has significant negative impacts) to any of the environmental objectives such as (1) climate change mitigation, (2) climate change adaptation, (3) sustainable use and protection of water and marine resources, (4) circular economy, (5) pollution prevention and control, (6) protection and restoration of biodiversity and ecosystems. Text automatically translated in your browsing language Automatically translated

33112200 - Ultrasonic unit

33112100 - Ultrasonic heart detector